Over the past two weeks, the Energy and Commerce Committee has passed nearly sixty bills to combat the opioid crisis including legislation authored by Congressman Bob Latta (R-Bowling Green), the INFO Act. That legislation was passed by the committee last week and would improve the availability of information on the epidemic for state and local governments, health care providers, law… Read more »
Today, legislation authored by Congressman Bob Latta (R-Bowling Green) to combat the opioid crisis, H.R. 4284, the Indexing Narcotics, Fentanyl, and Opioids (INFO) Act, was approved by the Energy and Commerce (E&C) Committee. The INFO Act helps state and local governments, advocates, health care providers, and law enforcement by collecting and aggregating data and information relating… Read more »
Bipartisan legislation introduced by Congressman Bob Latta (R-Bowling Green) to reform the outdated over-the-counter (OTC) monograph system was approved by the Energy and Commerce Committee this morning. The bill, H.R. 5333, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, modernizes the monograph framework and allows new, safe products to come to market more quickly… Read more »
Congressman Bob Latta (R-Bowling Green), a leader in Congress on addressing the opioid crisis, spoke about the impact of the epidemic for communities across Ohio at an Energy and Commerce (E&C) Subcommittee on Health hearing. The rare two-day hearing, entitled, “Combating the Opioid Crisis: Prevention and Public Health Solutions,” is focused on more than 20 different bills aimed at… Read more »
Congressman Bob Latta (R-OH) has introduced bipartisan legislation with members of the Energy and Commerce Committee to reform the outdated over-the-counter (OTC) monograph system. The legislation, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, modernizes the monograph framework and allows new, safe products to come to market more quickly while addressing safety issues… Read more »
At an Energy and Commerce Subcommittee on Health hearing, Congressman Bob Latta (R-Bowling Green) questioned an official from the Drug Enforcement Agency (DEA) about law enforcement efforts to combat the opioid epidemic and coordination between the agency and the Department of Health and Human Services (HHS). The hearing, entitled “Combatting the Opioid Crisis: Helping Communities Balance… Read more »
Congressman Bob Latta (R-Bowling Green) has asked the Food and Drug Administration (FDA) to look at ways that the Safeguarding America’s Pharmaceuticals Act — also known as “Track and Trace” — could be used to prevent opioids from being diverted from the supply chain and falling into the wrong hands. The Safeguarding America’s Pharmaceuticals Act was authored by Latta and was signed into… Read more »
This afternoon, the House Energy and Commerce (E&C) Committee announced that Congressman Bob Latta (R-Bowling Green) has been added to the Subcommittee on Health. The subcommittee has jurisdiction over private and public health insurance; biomedical research and development; health information technology; drug abuse; the regulation of food, drugs, and cosmetics; the Department of… Read more »
Congressman Bob Latta (R-Bowling Green) has introduced the Indexing Narcotics, Fentanyl, and Opioids (INFO) Act to improve and make available important data on the opioid crisis and the effect of federal efforts to combat the epidemic. The INFO Act would establish a public electronic database that would compile information on federal efforts to stop the opioid crisis. The information… Read more »
Congressman Bob Latta (R-Bowling Green) joined his colleagues in the U.S. House of Representatives in voting to repeal Obamacare’s Independent Payment Advisory Board (IPAB), an entity consisting of 15 unelected officials that have the authority to cut Medicare spending. H.R. 849, the Protecting Seniors’ Access to Medicare Act, passed with bipartisan support by a vote of 307 to 111. IPAB… Read more »
